Loading...

PRIVISCL Privi Speciality Chemicals Ltd Investments Divestments Announcement

Prv

PRVS

Privi Speciality Chemicals Ltd

(PRIVISCL)

2026 Announcement

Rating reaffirmation

Regulatory Compliance

Equity subscription in JV

Analyst / Investor Meeting

Trading Window Closure

Equity Investment

Analyst meeting cancellation

Earnings Call Transcript

Analyst / Investor Meet

Analyst / Investor Meet

Audio Recording / Analyst Call

Investor Presentation

Equity Investment

Equity investment

Financial results

Earnings Conference Call

Board meeting intimation

Regulatory compliance

SAST Disclosure

Equity Disinvestment

Trading Window Closure

Scheme of Amalgamation

Withdrawal of Scheme of Ama...

Earnings call transcript

Investor Meet Outcome

Investor Meetings

Investor Conference

Investor Meetings

Investor Meetings

Investor Presentation

Financial Results Update

Board Meeting Outcome

Earnings Call Scheduled

Saksham Niveshak Campaign

Board Meeting Notice

Compliance Certificate

Analyst Meeting

Investor Meet Scheduled

Earnings Call Transcript

Q1 Earnings Call

Investor Presentation

Board Meeting Outcome

Investor Call Scheduled

Compliance Certificate

AGM Notice Publication

Ecovadis Platinum Award

Investor Meeting

Board Meeting Outcome

Merger Announcement

Investor Meeting Scheduled

Annual Compliance Report

Investor Meeting

Earnings Call Transcript

Investor Meet Recording

Investor Presentation

Auditor Appointments

Earnings Call Scheduled

State Incentives Update

Compliance Certificate

Investor Meet Schedule

Director Resignation

Cautionary Letter

Director Resignation

Credit Rating Upgrade

Investor Meet Scheduled

Investor Meeting Scheduled

Investor Meet Outcome

Investor Meet Result

Investor Presentation

Board Meeting Outcome

Director Resignation

Trishul Award Won

Regulatory Compliance

Postal Ballot Notice

Investor Meetings

Employee Stock Options

Investor Meeting

Investor Meeting

Investor Meeting Scheduled

Analyst/Investor Meet

Analyst Call Summary

Investor Presentation

Management Changes

Earnings Call Invitation

FDA Registration

Compliance Certificate

New Facility Operations

Investor Meetings

Analyst Meetings

Audio Recording

Investor Presentation

Financial Results and Inves...

Earnings Conference Call

Newspaper Advertisement

Certificate Submission

Business Development Call

Project Expansion

Audio Recording

Analyst Meeting Outcome

Business Update Call

Investor Presentation

Acquisition Approval

Analyst Meeting Intimation

Investor Conference

Credit Rating Revision

Analyst/Investor Meet

Analyst Meet Outcome

Annual Compliance Report

Financial Results Discussion

Investor Presentation

Re-appointment of Chairman ...

Earnings Conference Call

Compliance Certificate Subm...

Investment in SPV

Compliance Certificate

Certificate Submission

Meeting Transcript

Investor Meeting Outcome

Financial Results

Earnings Conference Call

Regulation 74(5) Certificate

Advertisement Publication

Appointment Of Additional D...

Earnings Conference Call

Certificate Submission

Financial Statements

Management Changes

Certificate Submission

Analyst/Investor Meet

Investor Meetings

Investment disclosure

Financial Statements Approval

Rights Offerings

Equity Investment

External Links:

Data:

Privi and Givaudan subscribe to JV equity in Prigiv Specialties Private Limited; post-allotment equity shares show Privi 51% and Givaudan 49% with updated paid-up capital per March 26, 2026 approvals.

AI Assistant

Privi Speciality Chemicals Ltd

2026

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.